These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27223158)

  • 1. Postmenopausal Osteoporosis.
    Michaëlsson K; Aspenberg P
    N Engl J Med; 2016 May; 374(21):2095. PubMed ID: 27223158
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmenopausal Osteoporosis.
    Black DM; Rosen CJ
    N Engl J Med; 2016 May; 374(21):2096-7. PubMed ID: 27223157
    [No Abstract]   [Full Text] [Related]  

  • 3. Postmenopausal Osteoporosis.
    Ott SM
    N Engl J Med; 2016 May; 374(21):2095-6. PubMed ID: 27223159
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmenopausal Osteoporosis.
    Cheung AM; Papaioannou A; Morin S;
    N Engl J Med; 2016 May; 374(21):2096. PubMed ID: 27223160
    [No Abstract]   [Full Text] [Related]  

  • 5. [Does ibandronate (Bonviva) have an impact on non-vertebral fractures?].
    Kastelan D; Vlak T
    Reumatizam; 2007; 54(2):87-8. PubMed ID: 18351153
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonates for osteoporosis.
    Favus MJ
    N Engl J Med; 2010 Nov; 363(21):2027-35. PubMed ID: 21083387
    [No Abstract]   [Full Text] [Related]  

  • 7. In postmenopausal women with osteoporosis, is zoledronic acid (Reclast) superior in improving T-scores and decreasing fracture rates when compared with placebo?
    Bilbao J; Pugh A; Aspy CB
    J Okla State Med Assoc; 2010 Aug; 103(8):374-5. PubMed ID: 21049709
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence with bisphosphonate therapy in older people.
    Melo M; Qiu F; Sykora K; Juurlink D; Laupacis A; Mamdani M
    J Am Geriatr Soc; 2006 Jun; 54(6):1015-6. PubMed ID: 16776810
    [No Abstract]   [Full Text] [Related]  

  • 9. Postmenopausal osteoporosis: another approach to management.
    Cole R
    J Fam Pract; 2010 Jun; 59(6):E1-7. PubMed ID: 20544058
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ibandronate once a month].
    Polk B
    Med Monatsschr Pharm; 2006 Jan; 29(1):36-7. PubMed ID: 16463553
    [No Abstract]   [Full Text] [Related]  

  • 11. When do bisphosphonates make the most sense?
    Winzenberg T; Jones G
    J Fam Pract; 2011 Jan; 60(1):18-28. PubMed ID: 21209974
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of osteoporosis-related fractures among postmenopausal women and older men.
    Rahmani P; Morin S
    CMAJ; 2009 Nov; 181(11):815-20. PubMed ID: 19841053
    [No Abstract]   [Full Text] [Related]  

  • 13. Ask the doctor. I'm looking for information on Prolia and Reclast as alternatives to Boniva.
    Robb-Nicholson C
    Harv Womens Health Watch; 2011 Nov; 19(3):8. PubMed ID: 22276325
    [No Abstract]   [Full Text] [Related]  

  • 14. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
    Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
    Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New bone density conservation agents for osteoporosis under research and development: Minodronic acid].
    Takata S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():417-20. PubMed ID: 18161142
    [No Abstract]   [Full Text] [Related]  

  • 16. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I;
    Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Under-use of bisphosphonates in rural elderly women who have sustained fractures.
    Naunton M; Peterson G; Jones G
    Aust J Rural Health; 2006 Dec; 14(6):286. PubMed ID: 17121511
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates.
    Al-Azzawi F
    Gynecol Endocrinol; 2008 Nov; 24(11):601-9. PubMed ID: 19031214
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of bisphosphonates in the management of postmenopausal osteoporosis.
    Papapoulos SE
    Ann N Y Acad Sci; 2011 Feb; 1218():15-32. PubMed ID: 20946579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Practice. Postmenopausal Osteoporosis.
    Black DM; Rosen CJ
    N Engl J Med; 2016 Jan; 374(3):254-62. PubMed ID: 26789873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.